These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28956331)

  • 1. Phosphodiesterase-4B as a Therapeutic Target for Cognitive Impairment and Obesity-Related Metabolic Diseases.
    Clapcote SJ
    Adv Neurobiol; 2017; 17():103-131. PubMed ID: 28956331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The therapeutic potential of metabolic hormones in the treatment of age-related cognitive decline and Alzheimer's disease.
    Grizzanti J; Lee HG; Camins A; Pallas M; Casadesus G
    Nutr Res; 2016 Dec; 36(12):1305-1315. PubMed ID: 27923524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of spatial memory function in APPswe/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D.
    Sierksma AS; van den Hove DL; Pfau F; Philippens M; Bruno O; Fedele E; Ricciarelli R; Steinbusch HW; Vanmierlo T; Prickaerts J
    Neuropharmacology; 2014 Feb; 77():120-30. PubMed ID: 24067928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Inhibition of Phosphodiesterase 4B (PDE4B) Instills Cognitive Resilience in APPswe/PS1dE9 Mice.
    Rombaut B; Schepers M; Tiane A; Mussen F; Koole L; Kessels S; Trippaers C; Jacobs R; Wouters K; Willems E; Veggel LV; Koulousakis P; Deluyker D; Bito V; Prickaerts J; Wens I; Brône B; van den Hove DLA; Vanmierlo T
    Cells; 2024 Jun; 13(12):. PubMed ID: 38920631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of phosphodiesterase-4 subtypes involved in surgery-induced neuroinflammation and cognitive dysfunction in mice.
    Wang W; Zhang XY; Feng ZG; Wang DX; Zhang H; Sui B; Zhang YY; Zhao WX; Fu Q; Xu ZP; Mi WD
    Brain Res Bull; 2017 Apr; 130():274-282. PubMed ID: 28235598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of hepatic cAMP levels via altered Pde4b expression plays a critical role in alcohol-induced steatosis.
    Avila DV; Barker DF; Zhang J; McClain CJ; Barve S; Gobejishvili L
    J Pathol; 2016 Sep; 240(1):96-107. PubMed ID: 27287961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase-4 inhibition as a therapeutic strategy for metabolic disorders.
    Wu C; Rajagopalan S
    Obes Rev; 2016 May; 17(5):429-41. PubMed ID: 26997580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From Age-Related Cognitive Decline to Alzheimer's Disease: A Translational Overview of the Potential Role for Phosphodiesterases.
    Heckman PRA; Blokland A; Prickaerts J
    Adv Neurobiol; 2017; 17():135-168. PubMed ID: 28956332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of resveratrol on beta amyloid-induced memory impairment involves inhibition of phosphodiesterase-4 related signaling.
    Wang G; Chen L; Pan X; Chen J; Wang L; Wang W; Cheng R; Wu F; Feng X; Yu Y; Zhang HT; O'Donnell JM; Xu Y
    Oncotarget; 2016 Apr; 7(14):17380-92. PubMed ID: 26980711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Past, Present, and Future of Phosphodiesterase-4 Modulation for Age-Induced Memory Loss.
    Hansen RT; Zhang HT
    Adv Neurobiol; 2017; 17():169-199. PubMed ID: 28956333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The unrecognized effects of phosphodiesterase 4 on epithelial cells in pulmonary inflammation.
    Konrad FM; Bury A; Schick MA; Ngamsri KC; Reutershan J
    PLoS One; 2015; 10(4):e0121725. PubMed ID: 25909327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting phosphodiesterase 4 as a therapeutic strategy for cognitive improvement.
    Wei X; Yu G; Shen H; Luo Y; Shang T; Shen R; Xi M; Sun H
    Bioorg Chem; 2023 Jan; 130():106278. PubMed ID: 36413930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coenzyme Q10 Improves Lipid Metabolism and Ameliorates Obesity by Regulating CaMKII-Mediated PDE4 Inhibition.
    Xu Z; Huo J; Ding X; Yang M; Li L; Dai J; Hosoe K; Kubo H; Mori M; Higuchi K; Sawashita J
    Sci Rep; 2017 Aug; 7(1):8253. PubMed ID: 28811612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into PDE4B inhibitor selectivity: CoMFA analyses and molecular docking studies.
    Guariento S; Bruno O; Fossa P; Cichero E
    Mol Divers; 2016 Feb; 20(1):77-92. PubMed ID: 26290462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and metabolic alterations in the hippocampus caused by insulin signalling dysfunction and its association with cognitive impairment during aging and Alzheimer's disease: studies in animal models.
    Calvo-Ochoa E; Arias C
    Diabetes Metab Res Rev; 2015 Jan; 31(1):1-13. PubMed ID: 24464982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memory-enhancing effects of GEBR-32a, a new PDE4D inhibitor holding promise for the treatment of Alzheimer's disease.
    Ricciarelli R; Brullo C; Prickaerts J; Arancio O; Villa C; Rebosio C; Calcagno E; Balbi M; van Hagen BT; Argyrousi EK; Zhang H; Pronzato MA; Bruno O; Fedele E
    Sci Rep; 2017 Apr; 7():46320. PubMed ID: 28402318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDE4D: A Multipurpose Pharmacological Target.
    Lusardi M; Rapetti F; Spallarossa A; Brullo C
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitor of Phosphodiestearse-4 improves memory deficits, oxidative stress, neuroinflammation and neuropathological alterations in mouse models of dementia of Alzheimer's Type.
    Kumar A; Singh N
    Biomed Pharmacother; 2017 Apr; 88():698-707. PubMed ID: 28152479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential PDE4B inhibitors as promising candidates against SARS-CoV-2 infection.
    Giuzio F; Bonomo MG; Catalano A; Infantino V; Salzano G; Monné M; Geronikaki A; Petrou A; Aquaro S; Sinicropi MS; Saturnino C
    Biomol Concepts; 2023 Jan; 14(1):. PubMed ID: 37909122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of phosphodiesterase 4B (PDE4B) activates protein kinase A and contributes to the progression of prostate cancer.
    Kashiwagi E; Shiota M; Yokomizo A; Itsumi M; Inokuchi J; Uchiumi T; Naito S
    Prostate; 2012 May; 72(7):741-51. PubMed ID: 22529021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.